Cleared Special

K100315 - 12 LEAD GLOVE

K100315 is an FDA 510(k) clearance for 12 LEAD GLOVE, manufactured by I Needmd, Inc.. The device is a Class 2 Cardiovascular device with product code DRX cleared through the Special 510(k) pathway after a 78-day FDA review.

K100315 · I Needmd, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2010
Decision
78d
Days
Class 2
Risk

K100315 is an FDA 510(k) clearance for the 12 LEAD GLOVE. Classified as Electrode, Electrocardiograph (product code DRX), Class II - Special Controls.

Submitted by I Needmd, Inc. (New York, US). The FDA issued a Cleared decision on April 23, 2010 after a review of 78 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2360 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all I Needmd, Inc. devices

FDA 510(k) Submission Details - K100315

510(k) Number K100315 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 04, 2010
Decision Date April 23, 2010
Days to Decision 78 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
47d faster than avg
Panel avg: 125d · This submission: 78d
Pathway characteristics
Modification to existing cleared device.

DRX Device Classification - Class 2, Special Controls

Product Code DRX Electrode, Electrocardiograph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2360
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DRX Electrode, Electrocardiograph

All 154
Devices cleared under the same product code (DRX) and FDA review panel - the closest regulatory comparables to K100315.
AMBU BLUE SENSOR NEO, AMBU BLUE SENSOR NEO X
K100129 · Ambu A/S · Jun 2010
SKINTACT AND VARIOUS OTHER TRADENAMES
K092291 · Leonhard Lang GmbH · Aug 2009
CONMED ECG MONITORING ELECTRODES , MODEL 1700 ( INCLUDING 2500), 1750, 2700, 2710, 1800, SERIES
K091856 · Conmed Corporation · Aug 2009
TELECTRODE WET GEL ECG ELECTRODE
K083148 · Bio Protech, Inc. · Nov 2008
SKINTACT PRE-WIRED ECG ELECTRODES WITH CONDUCTIVE ADHESIVE
K080106 · Leonhard Lang GmbH · Feb 2008
SKINTACT AND VARIOUS OTHER TRADENAMES
K073104 · Leonhard Lang GmbH · Nov 2007